REVELATION BIOSCIENCES, INC. Conversion of Stock, Shares Converted
REVELATION BIOSCIENCES, INC. (REVB) had Conversion of Stock, Shares Converted of 3 shares as of 2025-07-07, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-02-26
- 2025-07-07: Conversion of Stock, Shares Converted 3.00 shares.
- 2025-01-28: Conversion of Stock, Shares Converted 16.00 shares.
- 2024-01-25: Conversion of Stock, Shares Converted 30.00 shares.
- 2024-01-22: Conversion of Stock, Shares Converted 30.00 shares.
| Period end | Conversion of Stock, Shares Converted |
|---|---|
| 2025-07-07 | 3.00 shares 10-K · filed 2026-02-26 |
| 2025-01-28 | 16.00 shares 10-K · filed 2026-02-26 |
| 2024-01-25 | 30.00 shares 10-K · filed 2026-02-26 |
| 2024-01-22 | 30.00 shares 10-K · filed 2025-03-06 |
| 2023-01-30 | 35.00 shares 10-K/A · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |